A multi-criteria decision analysis (MCDA) tool for purchasing off-patent oncology medicines in Egypt.
Elezbawy B, Fasseeh AN, Sedrak A, Eldessouki R, Gamal M, Eldebeiky M, Amer H, Akeel S, Morsy A, Amin A, Shafik A, Abaza S, Kaló Z.
Elezbawy B, et al. Among authors: kalo z.
J Pharm Policy Pract. 2022 Mar 1;15(1):10. doi: 10.1186/s40545-022-00414-2.
J Pharm Policy Pract. 2022.
PMID: 35232487
Free PMC article.